HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Accepted manuscript (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Simmen, R. Articles by Simmen, F. PubMed PubMed Citation Articles by Simmen, R. Articles by Simmen, F.

R Simmen, Physiology & Biophysics, University of Arkansas for Medical Sciences, Little Rock, United States
J Pabona, Physiology & Biophysics, University of Arkansas for Medical Sciences, Little Rock, United States
M Velarde, Buck Institute for Age Research, Novato, United States
C Simmons, Physiology & Biophysics, University of Arkansas for Medical Sciences, Little Rock, United States
O Rahal, Interdisciplinary Biomedical Sciences Program, University of Arkansas for Medical Sciences, Little Rock, United States
F Simmen, Physiology & Biophysics, University of Arkansas for Medical Sciences, Little Rock, United States

Correspondence: Rosalia Simmen, Email: SimmenRosalia{at}uams.edu

Krüppel-like factors (KLFs), of which there are currently 17 known protein members, belong to the Specificity-protein (Sp) family of transcription factors and are characterized by the presence of Cys2/His2 zinc-finger motifs in their carboxy-terminal domains that confer preferential binding to GC/GT-rich sequences in gene promoter and enhancer regions. While previously regarded to simply function as silencers of Sp1-transactivity, many KLFs are now shown to be relevant to human cancers by their newly identified abilities to mediate cross-talk with signaling pathways involved in the control of cell proliferation, apoptosis, migration, and differentiation. Several KLFs act as tumor suppressors and/or oncogenes under distinct cellular contexts, underscoring their prognostic potential for cancer survival and outcome. Recent studies suggest that a number of KLFs can influence steroid hormone signaling through transcriptional networks involving steroid hormone receptors and members of the nuclear receptor family of transcription factors. Since inappropriate sensitivity or resistance to steroid hormone actions underlie endocrine-related malignancies, we consider the intriguing possibility that dysregulation of expression and/or activity of KLF members is linked to the pathogenesis of endometrial and breast cancers. In this review, we focus on recently described mechanisms of actions of several KLFs (KLF4, KLF5, KLF6, and KLF9) in cancers of the mammary gland and uterus. We suggest that understanding the mode of actions of KLFs and their functional networks may lead to the development of novel therapeutics to improve current prospects for cancer prevention and cure.